Alto Neuroscience, Inc. Debt-to-equity in % from Q3 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alto Neuroscience, Inc. quarterly Debt-to-equity history and growth rate from Q3 2024 to Q3 2025.
  • Alto Neuroscience, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 24.5 %, a 46.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Alto Neuroscience, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 24.5 +7.83 +46.9% Sep 30, 2025
Q2 2025 20.7 Jun 30, 2025
Q1 2025 16.2 Mar 31, 2025
Q4 2024 12.6 Dec 31, 2024
Q3 2024 16.7 Sep 30, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.